T2 Biosystems Inc (TTOO)
0.4346
+0.01
(+2.07%)
USD |
NASDAQ |
Nov 22, 10:27
T2 Biosystems Profit Margin (Quarterly): -509.7% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -509.7% |
| June 30, 2024 | -459.2% |
| March 31, 2024 | -656.7% |
| December 31, 2023 | -615.8% |
| September 30, 2023 | -1.05K% |
| June 30, 2023 | -323.2% |
| March 31, 2023 | -864.5% |
| December 31, 2022 | -184.2% |
| September 30, 2022 | -472.5% |
| June 30, 2022 | -305.1% |
| March 31, 2022 | -228.0% |
| December 31, 2021 | -174.0% |
| September 30, 2021 | -188.0% |
| June 30, 2021 | -186.4% |
| March 31, 2021 | -153.2% |
| December 31, 2020 | -127.2% |
| September 30, 2020 | -214.6% |
| June 30, 2020 | -418.7% |
| March 31, 2020 | -587.4% |
| December 31, 2019 | -457.5% |
| September 30, 2019 | -845.0% |
| June 30, 2019 | -867.4% |
| March 31, 2019 | -848.6% |
| Date | Value |
|---|---|
| December 31, 2018 | -845.4% |
| September 30, 2018 | -436.6% |
| June 30, 2018 | -313.5% |
| March 31, 2018 | -558.8% |
| December 31, 2017 | -1.10K% |
| September 30, 2017 | -1.27K% |
| June 30, 2017 | -1.62K% |
| March 31, 2017 | -1.56K% |
| December 31, 2016 | -1.60K% |
| September 30, 2016 | -1.18K% |
| June 30, 2016 | -1.42K% |
| March 31, 2016 | -1.22K% |
| December 31, 2015 | -1.19K% |
| September 30, 2015 | -1.11K% |
| June 30, 2015 | -1.95K% |
| March 31, 2015 | -5.65K% |
| December 31, 2014 | -7.63K% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -11.59K% |
| September 30, 2013 | -5.10K% |
| June 30, 2013 | -4.18K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.05K%
Minimum
Sep 2023
-127.2%
Maximum
Dec 2020
-408.7%
Average
-370.9%
Median
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Cardinal Health Inc | 0.80% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -150.6% |
| Return on Invested Capital | -478.2% |
| Gross Profit Margin (Quarterly) | -106.6% |
| Operating Margin (Quarterly) | -511.9% |
| Return on Net Operating Assets | -291.6% |